Stock listing

NYSE:BHVN Biohaven Pharmaceutical Holding Co Ltd Stock

Follow Biohaven Pharmaceutical Holding Co Ltd into a list and get an email when it puts out news.

Last close · NYSE:BHVN

$151.80 USD

Close on Oct 3, 2022 · No longer trades

May 4, 2017 to last close +767.4% · weekly closes, May 4, 2017 – Oct 3, 2022
Lowest – highest close
$17.50 – $152.20 USDSince May 4, 2017 · lowest May 4, 2017 · highest Sep 27, 2022

Delisted NYSE:BHVN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:BHVN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NYSE
Currency
USD

Biohaven Pharmaceutical Holding Co Ltd on 6ix

Sector
Health care
Industry
Biotechnology
Decks
12 decks · latest Sep 27, 2021

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Oct 29, 2026 · After close−6.5%
Quarter to Jun 30, 2026Aug 10, 2026 · After close−0.3%
Quarter to Mar 31, 2026May 4, 2026 · After close−4.2%
Quarter to Dec 31, 2025Mar 19, 2026−1.8%
Quarter to Sep 30, 2025Nov 10, 2025 · Before open−5.7%
Quarter to Jun 30, 2025Aug 11, 2025 · Before open−9.0%
Quarter to Mar 31, 2025May 12, 2025 · After close−5.1%
Quarter to Dec 31, 2024Mar 3, 2025−15.6%
Quarter to Sep 30, 2024Nov 12, 2024 · After close−2.6%
Quarter to Jun 30, 2024Aug 8, 2024 · After close+6.3%
All 20 quarters
QuarterResultsShare move
Quarter to Mar 31, 2024May 9, 2024 · After close−13.7%
Quarter to Dec 31, 2023Feb 29, 2024 · After close+2.9%
Quarter to Sep 30, 2023Nov 14, 2023 · After close−2.5%
Quarter to Jun 30, 2023Jul 31, 2023 · Before open+4.4%
Quarter to Mar 31, 2023May 12, 2023 · After close+6.9%
Quarter to Dec 31, 2022Mar 23, 2023 · After close+6.6%
Quarter to Sep 30, 2022Nov 9, 2022 · Before open−5.3%
Quarter to Jun 30, 2022Aug 5, 2022 · Before open
Quarter to Mar 31, 2022May 10, 2022 · Before open
Quarter to Dec 31, 2021Feb 25, 2022 · Before open

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2021)Investor deck89 slidesSep 27, 2021
Leerink Fireside Chat June 2021Conference23 slidesJun 29, 2021
Investor Presentation (June 2020)Investor deck76 slidesJun 2, 2020
Technical Presentation (March 2020)Technical8 slidesMar 31, 2020
Corporate Update (February 2020)Corporate update17 slidesFeb 28, 2020
Investor Presentation (January 2020)Investor deck71 slidesJan 13, 2020
Investor Presentation (October 2019)Investor deck67 slidesOct 3, 2019
Wells Fargo Healthcare Conference 2019Conference64 slidesSep 4, 2019
Technical Presentation (May 2019)Technical35 slidesMay 8, 2019
Corporate Update (December 2018)Corporate update15 slidesDec 3, 2018
All 12 decks
DeckKindSlidesDate
Technical Presentation (March 2018)Technical19 slidesMar 26, 2018
Investor Presentation (October 2017)Investor deck40 slidesOct 18, 2017

Open Decks

Cap table

Built by 6ix from Biohaven Pharmaceutical Holding Co Ltd’s releases

Common shares
151,043,781
Fully diluted
151,043,781

Fully diluted

LineShares
Common shares151,043,781

Share count over time

CountShares
Nov 22, 2026151,043,781

Open Cap table

Shareholders

HolderSharesValueAs of
Knoll Capital Management, LLC2.5MUS$33.8MSep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Vlad Coric
Other companies: Veradermics, Incorporated (Board Member · Since at least Feb 3, 2026); Royalty Pharma plc (Director · Since at least Apr 7, 2025); Biohaven Ltd. (Chairman & Chief Executive Officer · Since at least Sep 22, 2022); Revance Therapeutics, Inc. (Director · Mar 1, 2023 – Feb 4, 2025 · Past); Akili Inc (Director · Jun 29, 2021 – Jun 29, 2021 · Past)
Chief Executive Officer, Director · May 3, 2017 – Oct 3, 2022 · Past
Albert Cha
Other companies: Ascendis Pharma A/S (Chairman · Since at least Mar 18, 2026); KalVista Pharmaceuticals, Inc. (Director · Mar 23, 2017 – Sep 26, 2023 · Past); Aclaris Therapeutics, Inc. (Director · Oct 6, 2015 – Jun 29, 2016 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past)
Director · May 3, 2017 – May 1, 2018 · Past
Julia P. Gregory
Other companies: Biohaven Ltd. (Director · Since at least Sep 28, 2022); Nurix Therapeutics, Inc. (Chair · Since at least Jul 23, 2020); Lexicon Pharmaceuticals, Inc. (EVP and CFO · Feb 7, 2008 – Feb 7, 2008 · Past)
Director · Aug 2, 2017 – Oct 3, 2022 · Past
John W. Childs
Other companies: Veradermics, Incorporated (Chairman · Since at least Feb 3, 2026); Biohaven Ltd. (Director · Since at least Sep 28, 2022)
Director · Mar 22, 2019 – Oct 3, 2022 · Past
Declan Doogan
Other companies: Tenax Therapeutics, Inc. (Director · Since at least Feb 25, 2021)
Director · May 5, 2021 – Feb 11, 2022 · Past
Irina A. Antonijevic
Other companies: Biohaven Ltd. (Director · Since at least Sep 28, 2022)
Director · May 1, 2022 – Oct 3, 2022 · Past
John Tilton
Other companies: Biohaven Ltd. (Chief Commercial Officer, Rare Disease · Since at least Nov 4, 2026)
Chief Commercial Officer · May 3, 2017 – Oct 3, 2022 · Past
Kimberly Gentile
Other companies: Biohaven Ltd. (Senior Vice President, Clinical Operations · Since at least Sep 28, 2022)
SVP, Clinical Operations · May 3, 2017 – Oct 3, 2022 · Past
Matthew Buten
Other companies: Biohaven Ltd. (Chief Financial Officer · Since at least Sep 22, 2022)
Chief Financial Officer · Dec 8, 2021 – Oct 3, 2022 · Past
Robert Repella
Other companies: Vanda Pharmaceuticals Inc. (SVP & Chief Commercial Officer · Oct 24, 2011 – Nov 19, 2013 · Past)
Director · Sep 7, 2018 – May 21, 2019 · Past
All 12 people
PersonSeat
Charles ConwayChief Scientific Officer · May 3, 2017 – Oct 3, 2022 · Past
James EngelhartStrategic Advisor · May 3, 2017 – Oct 3, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Biohaven Pharmaceutical Holding Co Ltd.